Examining the Mechanism Behind Melanoma Drug Resistance
Zelboraf, which targets the mutated BRAF gene, is used to treat melanoma, but it isn’t always successful due to melanoma’s ability to sometimes get around…
Zelboraf News
Zelboraf Nearly Doubles Median Survival Time for Patients with Metastatic Melanoma
New research shows that the approved drug Zelboraf nearly doubles the median survival time for patients with metastatic melanoma. By following 132 patients, researchers found…
